CN Stock MarketDetailed Quotes

600436 Zhangzhou Pientzehuang Pharmaceutical

Watchlist
  • 236.00
  • -9.48-3.86%
Market Closed Nov 22 15:00 CST
142.38BMarket Cap46.24P/E (TTM)

Zhangzhou Pientzehuang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
24.17%3.27B
216.82%8.92B
-20.05%2.37B
-53.58%1.16B
8.98%2.63B
3.13%2.82B
-60.38%2.97B
-64.82%2.5B
-64.08%2.42B
-53.13%2.73B
Transactional financial assets
----
----
----
----
----
----
----
----
--5.81K
-28.39%16.41K
Notes receivable and accounts receivable
10.05%825.36M
12.60%854.5M
24.41%947.26M
18.42%968.48M
-3.82%750.01M
-2.47%758.89M
7.46%761.39M
23.12%817.86M
18.67%779.8M
18.04%778.09M
-Notes receivable
-35.92%33.93M
-24.28%44.93M
17.42%58.18M
-22.79%56.73M
31.58%52.94M
33.07%59.34M
50.37%49.55M
41.19%73.48M
18.71%40.24M
66.14%44.59M
-Accounts receivable
13.54%791.43M
15.73%809.57M
24.90%889.08M
22.48%911.75M
-5.75%697.07M
-4.63%699.55M
5.37%711.85M
21.58%744.38M
18.67%739.57M
16.00%733.5M
Other receivables (including interest and dividends)
-21.95%68.28M
-21.72%73.33M
-34.77%65.49M
-45.45%56.66M
-35.42%87.48M
-30.55%93.68M
-19.17%100.4M
-12.62%103.86M
48.75%135.46M
61.06%134.89M
-Dividend receivable
0.00%12M
12.59%20.72M
----
----
-9.09%12M
38.30%18.4M
----
----
--13.2M
90.52%13.3M
-Other receivable
----
-30.11%52.61M
----
----
----
-38.08%75.28M
----
-12.62%103.86M
----
58.38%121.58M
Advance payment
26.79%233.92M
-29.64%268.96M
126.52%353.39M
1.57%340.43M
-30.63%184.49M
89.75%382.29M
45.89%156.01M
74.56%335.18M
40.57%265.94M
47.94%201.47M
Inventories
64.13%4.57B
77.58%4.54B
43.23%3.88B
28.57%3.38B
18.46%2.78B
10.55%2.56B
8.47%2.71B
7.81%2.63B
5.66%2.35B
5.17%2.31B
Receivable financing
-35.38%42.65M
-42.47%58.85M
11.98%125.29M
26.75%52.77M
21.67%66M
173.33%102.28M
635.62%111.89M
362.75%41.63M
1.61%54.24M
48.03%37.42M
Other current assets
-10.38%6.84B
-94.38%409.62M
35.50%8.58B
45.56%9.14B
33.71%7.63B
32.18%7.28B
6,418.86%6.33B
5,820.82%6.28B
5,709.04%5.71B
5,970.82%5.51B
Total current assets
12.11%15.84B
8.10%15.13B
24.24%16.32B
18.85%15.1B
20.73%14.13B
19.54%13.99B
18.94%13.14B
19.48%12.7B
16.62%11.71B
29.76%11.7B
Non Current assets
Other equity investment
8.65%439.13M
-11.54%342.62M
-9.05%356.21M
0.38%377.1M
13.20%404.19M
3.01%387.33M
-1.34%391.66M
-20.18%375.68M
-24.16%357.07M
-20.18%376.03M
Other non-current financial assets
36.80%46.1M
36.86%46.12M
-7.88%46.17M
14.41%61.32M
-44.83%33.7M
-45.41%33.7M
-18.54%50.12M
-13.12%53.6M
-2.05%61.08M
5.57%61.73M
Investment real estate
-39.95%8.66M
-38.31%9.34M
-27.09%11.99M
-41.03%13.64M
-36.83%14.42M
-37.19%15.13M
-30.37%16.44M
-12.48%23.13M
-16.11%22.83M
-23.48%24.09M
Long-term equity investment
20.08%271.02M
-21.95%173.83M
-20.99%194.87M
-20.81%193.55M
-6.36%225.7M
-10.36%222.71M
-12.27%246.65M
-8.64%244.42M
-29.76%241.04M
-26.59%248.46M
Fixed assets
----
22.36%320.43M
----
----
----
0.28%261.87M
----
-1.17%260.89M
----
1.85%261.14M
Fixed assets liquidation
----
----
----
----
----
-96.73%1.29K
----
-98.37%1.24K
----
--39.5K
Constru in process
----
75.84%186.51M
----
----
----
161.79%106.07M
----
306.79%60.78M
----
1,428.99%40.52M
Productive biological assets
4.52%12.78M
3.91%12.45M
4.09%12.27M
5.44%12.22M
-5.95%12.22M
-6.31%11.99M
-5.53%11.78M
-6.69%11.59M
-1.84%13M
-6.21%12.79M
Intangible assets
-10.40%276.83M
-9.78%279.08M
-7.10%288.4M
-8.86%291.09M
8.38%308.94M
6.54%309.32M
47.14%310.45M
44.54%319.37M
20.61%285.06M
20.91%290.32M
Long deferred expense
-36.17%24.6M
-42.77%25.46M
-28.73%27.5M
-20.35%29.99M
4.92%38.54M
10.70%44.49M
-0.97%38.58M
-14.78%37.65M
-22.92%36.73M
-14.20%40.2M
Deferred tax assets
6.37%200.72M
6.46%190.25M
13.36%201.51M
11.99%187.31M
51.60%188.71M
36.73%178.71M
12.34%177.76M
0.17%167.26M
-2.34%124.48M
23.37%130.71M
Usufruct assets
9.97%131.56M
1.73%127.59M
5.89%135.97M
0.08%132.47M
-5.27%119.62M
-0.11%125.42M
22.24%128.41M
21.66%132.36M
12.80%126.28M
6.75%125.56M
Other non current assets
-17.20%178.61M
-5.02%207.39M
1.77%217.26M
-0.26%211.72M
-5.24%215.72M
-4.66%218.36M
-15.33%213.49M
-7.34%212.28M
1.22%227.64M
-2.86%229.03M
Adjustment items of non current assets
----
----
----
----
----
----
----
----
----
---0.01
Total non current assets
9.21%2.14B
0.31%1.92B
2.18%1.97B
4.29%1.98B
8.57%1.96B
4.05%1.92B
5.59%1.93B
0.60%1.9B
-6.86%1.81B
-4.06%1.84B
Total assets
11.75%17.99B
7.17%17.05B
21.41%18.29B
16.96%17.08B
19.10%16.1B
17.44%15.91B
17.05%15.07B
16.63%14.6B
12.82%13.51B
23.83%13.55B
Liabilities
Current liabilities
Short term loan
20.80%983.19M
14.38%1.02B
19.48%1.08B
1.95%989.93M
1.45%813.87M
12.41%892.72M
26.48%904.03M
25.16%970.96M
15.90%802.22M
14.99%794.14M
Notes payable and accounts payable
-4.12%417.9M
9.54%501.93M
83.97%767.54M
44.29%673.15M
8.49%435.85M
25.57%458.19M
41.18%417.22M
20.34%466.52M
25.26%401.74M
29.42%364.9M
-Notes payable
-93.45%4.85M
-71.28%31.03M
73.60%197.45M
61.47%167.29M
-3.45%74.03M
92.60%108.06M
82.05%113.74M
58.90%103.6M
13.93%76.67M
1,218.18%56.11M
-Accounts payable
14.16%413.05M
34.49%470.89M
87.85%570.09M
39.39%505.86M
11.31%361.82M
13.39%350.13M
30.22%303.48M
12.55%362.92M
28.27%325.06M
11.20%308.79M
Contract liabilities
-22.69%65.83M
-30.32%86.79M
-32.68%81.27M
-49.40%237.1M
7.59%85.15M
57.76%124.56M
3.59%120.72M
43.49%468.57M
31.80%79.14M
-29.22%78.95M
Advance receipts
-81.65%2.86M
215.55%9.56M
44.78%11.96M
-61.97%3.58M
17.58%15.6M
-64.83%3.03M
-15.55%8.26M
57.81%9.42M
-61.51%13.26M
-20.99%8.62M
Salaries payable
-5.77%151.5M
1.04%131.83M
4.53%140.41M
13.35%150.15M
77.62%160.77M
2.88%130.46M
21.09%134.33M
30.07%132.46M
-23.01%90.51M
12.90%126.81M
Taxs payable
-9.42%270.18M
-15.15%200.48M
48.84%315.81M
60.41%172.98M
40.36%298.27M
52.13%236.27M
-10.35%212.17M
-20.75%107.83M
-30.33%212.5M
-16.68%155.32M
Other payable (including interest and dividends)
179.78%1.17B
-50.06%540.12M
99.18%664.5M
120.06%595.47M
42.14%418.76M
-0.67%1.08B
-11.64%333.62M
-22.38%270.6M
-25.34%294.62M
166.56%1.09B
-Dividend payable
11,731.81%693.81M
-99.87%981.3K
7.31%7.45M
9.93%7.63M
0.00%5.86M
3.28%760.01M
18.41%6.94M
18.41%6.94M
0.00%5.86M
12,449.12%735.88M
-Other payable
----
67.68%539.13M
----
----
----
-8.90%321.53M
----
-23.08%263.66M
----
-12.34%352.95M
Non current liabilities due within one year
0.32%28.1M
-7.47%27.56M
0.71%29.76M
15.46%33.73M
36.58%28.01M
33.59%29.79M
70.94%29.55M
28.38%29.21M
--20.51M
--22.3M
Other current liabilities
-15.55%5.33M
-44.55%7.77M
-10.45%6.78M
-50.51%27.02M
-1.00%6.31M
109.84%14.01M
83.79%7.57M
71.75%54.59M
-52.68%6.38M
-38.99%6.68M
Total current liabilities
36.86%3.1B
-14.93%2.53B
42.94%3.1B
14.86%2.88B
17.79%2.26B
12.24%2.97B
15.10%2.17B
17.46%2.51B
-0.88%1.92B
45.96%2.65B
Current liabilities
Long term loan
73.86%51.42M
154.90%49.17M
--48.08M
--35.44M
--29.58M
--19.29M
----
----
----
----
Long term salaries pay
-1.58%33.99M
-0.47%34.78M
-0.46%34.59M
2.20%35.04M
7.21%34.54M
6.41%34.94M
6.52%34.75M
6.37%34.29M
12.11%32.22M
12.89%32.84M
Estimate liabilities
----
----
--6.61M
--12M
----
----
----
----
----
----
Deferred tax liabilities
-48.80%28.8M
-54.45%22.49M
-56.81%29.03M
-50.86%30.02M
172.28%56.24M
73.96%49.38M
61.17%67.22M
-18.02%61.09M
-57.92%20.66M
-37.19%28.38M
Long term deferred income
59.04%27.18M
24.31%21.94M
10.88%18.41M
3.87%17.67M
-9.40%17.09M
-10.65%17.65M
-17.88%16.6M
-15.97%17.01M
-23.01%18.86M
23.91%19.75M
Lease liabilities
14.37%111M
10.38%108.95M
10.51%114.5M
-1.39%107.29M
-11.90%97.05M
-6.20%98.71M
18.41%103.61M
25.53%108.8M
-1.30%110.16M
-8.66%105.23M
Other non current liabilities
-5.30%37.11M
-22.25%37.76M
-17.02%38.91M
-18.94%39.35M
26.57%39.18M
80.78%48.57M
56.58%46.89M
47.63%48.54M
-1.46%30.96M
-23.32%26.87M
Total non current liabilities
5.78%289.49M
2.44%275.09M
7.83%290.14M
2.63%276.81M
28.58%273.68M
26.03%268.53M
26.93%269.07M
9.40%269.72M
-13.25%212.85M
-11.39%213.07M
Total liabilities
33.50%3.39B
-13.49%2.8B
39.06%3.39B
13.67%3.16B
18.87%2.54B
13.27%3.24B
16.29%2.44B
16.63%2.78B
-2.27%2.13B
39.25%2.86B
Shareholders equity
Paid-in capital
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
0.00%603.32M
Capital reserve funds
0.07%1.1B
0.07%1.1B
0.08%1.09B
0.09%1.09B
-0.12%1.09B
-0.12%1.09B
0.73%1.09B
0.72%1.09B
0.90%1.1B
0.89%1.1B
Surplus reserve funds
18.68%1.61B
18.68%1.61B
18.68%1.61B
18.68%1.61B
21.17%1.35B
21.17%1.35B
21.17%1.35B
21.17%1.35B
26.17%1.12B
26.17%1.12B
Retained profit
7.44%10.59B
14.74%10.32B
22.23%10.97B
21.82%10B
22.87%9.86B
23.46%8.99B
21.48%8.98B
22.48%8.21B
22.21%8.02B
28.51%7.28B
Other composite income
27.31%127.68M
-45.28%47.3M
-32.18%58.85M
2.95%76.6M
67.64%100.29M
-29.02%86.45M
-36.49%86.77M
-62.81%74.41M
-70.99%59.83M
-41.03%121.8M
Shareholders equity without minority interests
7.80%14.02B
12.70%13.67B
18.34%14.33B
18.06%13.38B
19.36%13.01B
18.67%12.13B
17.24%12.11B
16.74%11.33B
16.62%10.9B
20.98%10.22B
Minority interests
5.12%580.2M
6.84%575.29M
10.30%572.94M
10.16%544.17M
14.34%551.92M
15.94%538.44M
16.11%519.44M
14.33%493.97M
7.17%482.71M
6.47%464.4M
Total shareholder equity
7.69%14.6B
12.45%14.24B
18.01%14.91B
17.73%13.92B
19.15%13.56B
18.55%12.67B
17.19%12.63B
16.64%11.82B
16.18%11.38B
20.27%10.69B
Total liabilityies and equity
11.75%17.99B
7.17%17.05B
21.41%18.29B
16.96%17.08B
19.10%16.1B
17.44%15.91B
17.05%15.07B
16.63%14.6B
12.82%13.51B
23.83%13.55B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Huaxing Certified Public Accountants Firm (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants Firm (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 24.17%3.27B216.82%8.92B-20.05%2.37B-53.58%1.16B8.98%2.63B3.13%2.82B-60.38%2.97B-64.82%2.5B-64.08%2.42B-53.13%2.73B
Transactional financial assets ----------------------------------5.81K-28.39%16.41K
Notes receivable and accounts receivable 10.05%825.36M12.60%854.5M24.41%947.26M18.42%968.48M-3.82%750.01M-2.47%758.89M7.46%761.39M23.12%817.86M18.67%779.8M18.04%778.09M
-Notes receivable -35.92%33.93M-24.28%44.93M17.42%58.18M-22.79%56.73M31.58%52.94M33.07%59.34M50.37%49.55M41.19%73.48M18.71%40.24M66.14%44.59M
-Accounts receivable 13.54%791.43M15.73%809.57M24.90%889.08M22.48%911.75M-5.75%697.07M-4.63%699.55M5.37%711.85M21.58%744.38M18.67%739.57M16.00%733.5M
Other receivables (including interest and dividends) -21.95%68.28M-21.72%73.33M-34.77%65.49M-45.45%56.66M-35.42%87.48M-30.55%93.68M-19.17%100.4M-12.62%103.86M48.75%135.46M61.06%134.89M
-Dividend receivable 0.00%12M12.59%20.72M---------9.09%12M38.30%18.4M----------13.2M90.52%13.3M
-Other receivable -----30.11%52.61M-------------38.08%75.28M-----12.62%103.86M----58.38%121.58M
Advance payment 26.79%233.92M-29.64%268.96M126.52%353.39M1.57%340.43M-30.63%184.49M89.75%382.29M45.89%156.01M74.56%335.18M40.57%265.94M47.94%201.47M
Inventories 64.13%4.57B77.58%4.54B43.23%3.88B28.57%3.38B18.46%2.78B10.55%2.56B8.47%2.71B7.81%2.63B5.66%2.35B5.17%2.31B
Receivable financing -35.38%42.65M-42.47%58.85M11.98%125.29M26.75%52.77M21.67%66M173.33%102.28M635.62%111.89M362.75%41.63M1.61%54.24M48.03%37.42M
Other current assets -10.38%6.84B-94.38%409.62M35.50%8.58B45.56%9.14B33.71%7.63B32.18%7.28B6,418.86%6.33B5,820.82%6.28B5,709.04%5.71B5,970.82%5.51B
Total current assets 12.11%15.84B8.10%15.13B24.24%16.32B18.85%15.1B20.73%14.13B19.54%13.99B18.94%13.14B19.48%12.7B16.62%11.71B29.76%11.7B
Non Current assets
Other equity investment 8.65%439.13M-11.54%342.62M-9.05%356.21M0.38%377.1M13.20%404.19M3.01%387.33M-1.34%391.66M-20.18%375.68M-24.16%357.07M-20.18%376.03M
Other non-current financial assets 36.80%46.1M36.86%46.12M-7.88%46.17M14.41%61.32M-44.83%33.7M-45.41%33.7M-18.54%50.12M-13.12%53.6M-2.05%61.08M5.57%61.73M
Investment real estate -39.95%8.66M-38.31%9.34M-27.09%11.99M-41.03%13.64M-36.83%14.42M-37.19%15.13M-30.37%16.44M-12.48%23.13M-16.11%22.83M-23.48%24.09M
Long-term equity investment 20.08%271.02M-21.95%173.83M-20.99%194.87M-20.81%193.55M-6.36%225.7M-10.36%222.71M-12.27%246.65M-8.64%244.42M-29.76%241.04M-26.59%248.46M
Fixed assets ----22.36%320.43M------------0.28%261.87M-----1.17%260.89M----1.85%261.14M
Fixed assets liquidation ---------------------96.73%1.29K-----98.37%1.24K------39.5K
Constru in process ----75.84%186.51M------------161.79%106.07M----306.79%60.78M----1,428.99%40.52M
Productive biological assets 4.52%12.78M3.91%12.45M4.09%12.27M5.44%12.22M-5.95%12.22M-6.31%11.99M-5.53%11.78M-6.69%11.59M-1.84%13M-6.21%12.79M
Intangible assets -10.40%276.83M-9.78%279.08M-7.10%288.4M-8.86%291.09M8.38%308.94M6.54%309.32M47.14%310.45M44.54%319.37M20.61%285.06M20.91%290.32M
Long deferred expense -36.17%24.6M-42.77%25.46M-28.73%27.5M-20.35%29.99M4.92%38.54M10.70%44.49M-0.97%38.58M-14.78%37.65M-22.92%36.73M-14.20%40.2M
Deferred tax assets 6.37%200.72M6.46%190.25M13.36%201.51M11.99%187.31M51.60%188.71M36.73%178.71M12.34%177.76M0.17%167.26M-2.34%124.48M23.37%130.71M
Usufruct assets 9.97%131.56M1.73%127.59M5.89%135.97M0.08%132.47M-5.27%119.62M-0.11%125.42M22.24%128.41M21.66%132.36M12.80%126.28M6.75%125.56M
Other non current assets -17.20%178.61M-5.02%207.39M1.77%217.26M-0.26%211.72M-5.24%215.72M-4.66%218.36M-15.33%213.49M-7.34%212.28M1.22%227.64M-2.86%229.03M
Adjustment items of non current assets ---------------------------------------0.01
Total non current assets 9.21%2.14B0.31%1.92B2.18%1.97B4.29%1.98B8.57%1.96B4.05%1.92B5.59%1.93B0.60%1.9B-6.86%1.81B-4.06%1.84B
Total assets 11.75%17.99B7.17%17.05B21.41%18.29B16.96%17.08B19.10%16.1B17.44%15.91B17.05%15.07B16.63%14.6B12.82%13.51B23.83%13.55B
Liabilities
Current liabilities
Short term loan 20.80%983.19M14.38%1.02B19.48%1.08B1.95%989.93M1.45%813.87M12.41%892.72M26.48%904.03M25.16%970.96M15.90%802.22M14.99%794.14M
Notes payable and accounts payable -4.12%417.9M9.54%501.93M83.97%767.54M44.29%673.15M8.49%435.85M25.57%458.19M41.18%417.22M20.34%466.52M25.26%401.74M29.42%364.9M
-Notes payable -93.45%4.85M-71.28%31.03M73.60%197.45M61.47%167.29M-3.45%74.03M92.60%108.06M82.05%113.74M58.90%103.6M13.93%76.67M1,218.18%56.11M
-Accounts payable 14.16%413.05M34.49%470.89M87.85%570.09M39.39%505.86M11.31%361.82M13.39%350.13M30.22%303.48M12.55%362.92M28.27%325.06M11.20%308.79M
Contract liabilities -22.69%65.83M-30.32%86.79M-32.68%81.27M-49.40%237.1M7.59%85.15M57.76%124.56M3.59%120.72M43.49%468.57M31.80%79.14M-29.22%78.95M
Advance receipts -81.65%2.86M215.55%9.56M44.78%11.96M-61.97%3.58M17.58%15.6M-64.83%3.03M-15.55%8.26M57.81%9.42M-61.51%13.26M-20.99%8.62M
Salaries payable -5.77%151.5M1.04%131.83M4.53%140.41M13.35%150.15M77.62%160.77M2.88%130.46M21.09%134.33M30.07%132.46M-23.01%90.51M12.90%126.81M
Taxs payable -9.42%270.18M-15.15%200.48M48.84%315.81M60.41%172.98M40.36%298.27M52.13%236.27M-10.35%212.17M-20.75%107.83M-30.33%212.5M-16.68%155.32M
Other payable (including interest and dividends) 179.78%1.17B-50.06%540.12M99.18%664.5M120.06%595.47M42.14%418.76M-0.67%1.08B-11.64%333.62M-22.38%270.6M-25.34%294.62M166.56%1.09B
-Dividend payable 11,731.81%693.81M-99.87%981.3K7.31%7.45M9.93%7.63M0.00%5.86M3.28%760.01M18.41%6.94M18.41%6.94M0.00%5.86M12,449.12%735.88M
-Other payable ----67.68%539.13M-------------8.90%321.53M-----23.08%263.66M-----12.34%352.95M
Non current liabilities due within one year 0.32%28.1M-7.47%27.56M0.71%29.76M15.46%33.73M36.58%28.01M33.59%29.79M70.94%29.55M28.38%29.21M--20.51M--22.3M
Other current liabilities -15.55%5.33M-44.55%7.77M-10.45%6.78M-50.51%27.02M-1.00%6.31M109.84%14.01M83.79%7.57M71.75%54.59M-52.68%6.38M-38.99%6.68M
Total current liabilities 36.86%3.1B-14.93%2.53B42.94%3.1B14.86%2.88B17.79%2.26B12.24%2.97B15.10%2.17B17.46%2.51B-0.88%1.92B45.96%2.65B
Current liabilities
Long term loan 73.86%51.42M154.90%49.17M--48.08M--35.44M--29.58M--19.29M----------------
Long term salaries pay -1.58%33.99M-0.47%34.78M-0.46%34.59M2.20%35.04M7.21%34.54M6.41%34.94M6.52%34.75M6.37%34.29M12.11%32.22M12.89%32.84M
Estimate liabilities ----------6.61M--12M------------------------
Deferred tax liabilities -48.80%28.8M-54.45%22.49M-56.81%29.03M-50.86%30.02M172.28%56.24M73.96%49.38M61.17%67.22M-18.02%61.09M-57.92%20.66M-37.19%28.38M
Long term deferred income 59.04%27.18M24.31%21.94M10.88%18.41M3.87%17.67M-9.40%17.09M-10.65%17.65M-17.88%16.6M-15.97%17.01M-23.01%18.86M23.91%19.75M
Lease liabilities 14.37%111M10.38%108.95M10.51%114.5M-1.39%107.29M-11.90%97.05M-6.20%98.71M18.41%103.61M25.53%108.8M-1.30%110.16M-8.66%105.23M
Other non current liabilities -5.30%37.11M-22.25%37.76M-17.02%38.91M-18.94%39.35M26.57%39.18M80.78%48.57M56.58%46.89M47.63%48.54M-1.46%30.96M-23.32%26.87M
Total non current liabilities 5.78%289.49M2.44%275.09M7.83%290.14M2.63%276.81M28.58%273.68M26.03%268.53M26.93%269.07M9.40%269.72M-13.25%212.85M-11.39%213.07M
Total liabilities 33.50%3.39B-13.49%2.8B39.06%3.39B13.67%3.16B18.87%2.54B13.27%3.24B16.29%2.44B16.63%2.78B-2.27%2.13B39.25%2.86B
Shareholders equity
Paid-in capital 0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M0.00%603.32M
Capital reserve funds 0.07%1.1B0.07%1.1B0.08%1.09B0.09%1.09B-0.12%1.09B-0.12%1.09B0.73%1.09B0.72%1.09B0.90%1.1B0.89%1.1B
Surplus reserve funds 18.68%1.61B18.68%1.61B18.68%1.61B18.68%1.61B21.17%1.35B21.17%1.35B21.17%1.35B21.17%1.35B26.17%1.12B26.17%1.12B
Retained profit 7.44%10.59B14.74%10.32B22.23%10.97B21.82%10B22.87%9.86B23.46%8.99B21.48%8.98B22.48%8.21B22.21%8.02B28.51%7.28B
Other composite income 27.31%127.68M-45.28%47.3M-32.18%58.85M2.95%76.6M67.64%100.29M-29.02%86.45M-36.49%86.77M-62.81%74.41M-70.99%59.83M-41.03%121.8M
Shareholders equity without minority interests 7.80%14.02B12.70%13.67B18.34%14.33B18.06%13.38B19.36%13.01B18.67%12.13B17.24%12.11B16.74%11.33B16.62%10.9B20.98%10.22B
Minority interests 5.12%580.2M6.84%575.29M10.30%572.94M10.16%544.17M14.34%551.92M15.94%538.44M16.11%519.44M14.33%493.97M7.17%482.71M6.47%464.4M
Total shareholder equity 7.69%14.6B12.45%14.24B18.01%14.91B17.73%13.92B19.15%13.56B18.55%12.67B17.19%12.63B16.64%11.82B16.18%11.38B20.27%10.69B
Total liabilityies and equity 11.75%17.99B7.17%17.05B21.41%18.29B16.96%17.08B19.10%16.1B17.44%15.91B17.05%15.07B16.63%14.6B12.82%13.51B23.83%13.55B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Huaxing Certified Public Accountants Firm (Special General Partnership)------Huaxing Certified Public Accountants Firm (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data